Cancer Therapy News and Research

RSS

Researchers reveal how some cancers trick healthy cells into protecting tumors

Many factors affect cancer treatment outcome, such as the size and location of the tumor, availability of effective treatments, and timing of intervention. But some cancers are so aggressive that outcome is poor, even after early diagnosis and chemotherapy.

30 Nov 2018

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

Adoptive cell transfer is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable of targeting their tumor, selecting the more active T cells and expanding those in the lab, and then transfusing them back into patients.

30 Nov 2018

First-ever European Meeting on CAR T Cell Therapy represents educational opportunity for healthcare professionals

CAR T Cell Therapy is revolutionizing the field of hematologic malignancies and has the potential to achieve cure for a number of dreadful diseases.

29 Nov 2018

New Mainz-based Collaborative Research Center aims to explore DNA repair and genome stability

From January 1, 2019, the German Research Foundation will be funding the new Collaborative Research Center 1361 on Regulation of DNA Repair & Genome Stability.

29 Nov 2018

Study presents new opportunities for targeted, healthy tissue-sparing cancer therapy

Medical physicist Dr. Aswin Hoffmann and his team from the Institute of Radiooncology - OncoRay at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) are the first researchers worldwide to combine magnetic resonance imaging (MRI) with a proton beam, thus demonstrating that in principle, this commonly used imaging method can indeed work with particle beam cancer treatments.

29 Nov 2018

New accelerator-based technology aims to reduce side effects of cancer radiation therapy

New accelerator-based technology being developed by the Department of Energy's SLAC National Accelerator Laboratory and Stanford University aims to reduce the side effects of cancer radiation therapy by shrinking its duration from minutes to under a second.

29 Nov 2018

Researchers examine the experiences of veterans receiving both cancer treatment and hospice care

Veterans Health Administration hospitals offer something Medicare does not: In some cases, treatments meant to alter the course of a disease can be offered along with hospice care.

28 Nov 2018

New therapeutic drug monitoring service could benefit children with cancer

Children with cancer are to benefit nationally from a service which for the first time will allow doctors to personalize their treatment.

28 Nov 2018

Research may pave way for development of potent weapons against cancer

Despite significant advances in cancer research, the disease continues to exact a devastating toll. Because cancer is a disease of the body's own cells, which mutate and develop under evolutionary pressure, conventional treatments like chemotherapy and radiation often leave behind a residue of resistant cells that go on to expand and wreak havoc.

27 Nov 2018

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

Some severe forms of leukemia develop because proteins on the epigenetic level lose their regulative function. Now, in a broad international collaboration, UK researchers have identified molecules that can effectively inhibit the dysregulated proteins.

27 Nov 2018

Citrate-based biomaterial could help in better bone repair

A material based on a natural product of bones and citrus fruit, called citrate, provides the extra energy that stem cells need to form new bone tissue, according to a team of Penn State bioengineers.

27 Nov 2018

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker).

27 Nov 2018

Biological aging caused by cancer treatments correlates with cognitive decline

Cancer treatments are suspected to accelerate certain aging processes in the body. A new study has found that indicators of such biological aging correlate with declines in cognitive function in women who had undergone breast cancer treatment several years earlier.

26 Nov 2018

Japan-India collaboration results in new treatment approach for male urethral stricture

A novel and relatively pain-less treatment method for male urethral stricture using patients own buccal mucosal cells has been reported as successful in four out of six patients.

25 Nov 2018

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

One of the most successful techniques to combat multidrug resistance in cancer cells is the downregulation of those genes responsible for drug resistance.

22 Nov 2018

Nutritional supplement can slow cancer growth and enhance effects of chemotherapy

Mannose sugar, a nutritional supplement, can both slow tumor growth and enhance the effects of chemotherapy in mice with multiple types of cancer.

21 Nov 2018

Sugar supplement shown to slow tumor growth and enhance chemotherapy

Mannose, a type of sugar, has been shown to slow tumor growth and enhance chemotherapy in mouse models of certain cancers.

21 Nov 2018

Researchers awarded $7 million funding in Pancreatic Cancer Collective’s 'New Therapies Challenge'

The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer, has awarded a total of $7 million in first-round "New Therapies Challenge" grants to seven teams of top cancer researchers to explore new pancreatic cancer treatments, the American Association for Cancer Research, the Scientific Partner of SU2C, announced today.

21 Nov 2018

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

The Abramson Cancer Center (ACC) at the University of Pennsylvania announced today that it is joining the National Comprehensive Cancer Network (NCCN) as its 28th member institution.

20 Nov 2018

New solution to stop spread of brain cancer

The tissues in our bodies largely are made of fluid. It moves around cells and is essential to normal body function.

19 Nov 2018

Cancer Therapy News and Research

Researchers reveal how some cancers trick healthy cells into protecting tumors

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

First-ever European Meeting on CAR T Cell Therapy represents educational opportunity for healthcare professionals

New Mainz-based Collaborative Research Center aims to explore DNA repair and genome stability

Study presents new opportunities for targeted, healthy tissue-sparing cancer therapy

New accelerator-based technology aims to reduce side effects of cancer radiation therapy

Researchers examine the experiences of veterans receiving both cancer treatment and hospice care

New therapeutic drug monitoring service could benefit children with cancer

Research may pave way for development of potent weapons against cancer

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

Citrate-based biomaterial could help in better bone repair

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

Biological aging caused by cancer treatments correlates with cognitive decline

Japan-India collaboration results in new treatment approach for male urethral stricture

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

Nutritional supplement can slow cancer growth and enhance effects of chemotherapy

Sugar supplement shown to slow tumor growth and enhance chemotherapy

Researchers awarded $7 million funding in Pancreatic Cancer Collective’s 'New Therapies Challenge'

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

New solution to stop spread of brain cancer

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News